Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Genprex Inc (NQ: GNPX ) 0.6891 -0.0109 (-1.56%) Streaming Delayed Price Updated: 1:58 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 69,811 Open 0.6900 Bid (Size) 0.6700 (50) Ask (Size) 0.6892 (3) Prev. Close 0.7000 Today's Range 0.6700 - 0.6900 52wk Range 0.5644 - 22.41 Shares Outstanding 59,409,822 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Positive Clinical Results with Promising Gene Therapy Treatment for Late Stage Lung Cancer; Life-Changing Developments for Cancer and Diabetes: Genprex, Inc. (Nasdaq: GNPX) August 22, 2024 Via Get News Topics Intellectual Property Exposures Intellectual Property Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results August 13, 2024 Via Benzinga Exposures Fossil Fuels Performance YTD -92.64% -92.64% 1 Month -61.72% -61.72% 3 Month -70.92% -70.92% 6 Month -83.47% -83.47% 1 Year -96.29% -96.29% More News Read More S&P 500 Gains 1%; Home Depot Earnings Top Views August 13, 2024 Via Benzinga Topics Stocks Exposures US Equities Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July August 13, 2024 Via Benzinga GNPX Stock Earnings: Genprex Reported Results for Q2 2024 August 12, 2024 Via InvestorPlace GNPX Stock Earnings: Genprex Beats EPS for Q1 2024 May 20, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Friday's Intraday Session May 31, 2024 Via Benzinga Clinical Trials Commenced for Promising Acclaim-3 Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer: Genprex, Inc. (NASDAQ: GNPX) May 14, 2024 Via Get News New Company Officers Appointed After Promising Preclinical Data on Gene Therapy for Anti-Tumor Mechanisms with Ability to Trigger Cancer Cell Death: Genprex, Inc. (NASDAQ: GNPX) May 13, 2024 Via Get News BioMedNewsBreaks — Genprex Inc. (NASDAQ: GNPX) Announces Participation at Upcoming Investor, Industry Events May 01, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety 12 Health Care Stocks Moving In Friday's Pre-Market Session April 26, 2024 Via Benzinga BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Positive Preclinical Data Supporting NPRL2 Gene Therapy April 02, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Closes on $6.5M Registered Direct Offering March 25, 2024 Via Investor Brand Network Exposures Product Safety TechMediaBreaks – Genprex Inc. (NASDAQ: GNPX) Closes on $6.5M Registered Direct Offering March 25, 2024 Via Investor Brand Network Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's Intraday Session March 19, 2024 Via Benzinga TinyGemsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $6.5M Registered Direct Offering March 19, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $6.5M Registered Direct Offering March 19, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Adds Korean Patent for Leading Drug Candidate to Growing International Patent Portfolio March 13, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 06, 2024 Via Benzinga InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Preclinical Data to be Presented at Upcoming AACR Annual Meeting March 06, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces New Research Collaborations, Expansion of Nonclinical Programs into New Therapeutic Indications February 07, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces New Research Collaborations, Expansion of Nonclinical Programs into New Therapeutic Indications February 07, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation at This Month’s BIO CEO & Investor Conference February 06, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Phase2a Expansion of Acclaim-1 Clinical Study Enrolls, Doses First Patient February 05, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Phase2a Expansion of Acclaim-1 Clinical Study Enrolls, Doses First Patient February 05, 2024 Via Investor Brand Network Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
